John Paul Johnson - Mar 1, 2024 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Chief Financial Officer
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Stock symbol
EVH
Transactions as of
Mar 1, 2024
Transactions value $
-$696,218
Form type
4
Date filed
3/5/2024, 07:09 PM
Previous filing
Feb 26, 2024
Next filing
Aug 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Award $0 +12.1K +5.41% $0.00 236K Mar 1, 2024 Direct F1, F2, F3
transaction EVH Class A Common Stock Tax liability -$386K -11.2K -4.75% $34.41 225K Mar 1, 2024 Direct F3, F4
transaction EVH Class A Common Stock Tax liability -$310K -9.02K -4.01% $34.41 216K Mar 2, 2024 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
F2 Securities vest at a rate of 34% on March 1, 2025, and 33% on March 1, 2026, and March 1, 2027.
F3 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F4 This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.